Updates from the 2023 International Bipolar Conference, including new diagnostic tools for bipolar disorder. Stanford researchers propose a new subtype of depression.CME: Take the CME Post-Test for this EpisodePublished On: 07/10/2023Duration: 30 minutes, 43 secondsChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Chris Aiken and Kellie Newsome discuss controversies around Auvelity, a fast-acting antidepressant, examining side effects, addictive potential, and generic components. They explore the combination of dextromethorphan and bupropion, generic substitution risks, treatment options for resistant depression, and concerns about long-term efficacy and medication use.

Learn about stimulant dosing in psychiatry with Chris Aiken, MD and Kellie Newsome, PMHNP. Topics include challenges in diagnosing adult ADHD, risks of high stimulant doses, optimal dosing of Adderall XR, maximizing ADHD treatment, exploring methylphenidate dosage and effects.

Psychiatrist Chris Aiken, MD, and Psychiatric Nurse Practitioner Kellie Newsome discuss the generic form of Vilazodone, exploring its efficacy in managing depression and anxiety disorders, its impact on treating anxious depression, and its tolerability compared to SSRIs. They highlight the importance of understanding the drug's mechanism of action, onset of action, and remission rates from trials and studies.

Dr. Aiken and Kellie discuss Auvelity, a fast-acting antidepressant, exploring its pharmacodynamics, benefits of pairing with bupropion, and update on treatment-resistant depression trial. They also delve into Aveleti's efficacy in depression treatment and ongoing studies.